Pol θ has been shown to conduct microhomology-mediated end-joining (MMEJ) (also known as theta-mediated end-joining or TMEJ) in the absence of functional BRCA1 and/or BRCA2 in cancer cells. This evidence concerns the gene BRCA2 and cancer.